Back to search results

ACT Lung Health Intervention for Smoking Cessation in Chinese and Korean Americans

This study is testing a program called ACT Lung Health Intervention to help Chinese and Korean American smokers quit. This program offers individual counseling, family coaching, nicotine replacement therapy (like patches or gum), and information about lung cancer screening (LDCT). You might be able to join if you are 18 or older, identify as Chinese or Korean, speak Korean, Mandarin, or English, and currently smoke. The study wants to see if participants can successfully quit smoking for at least 7 days, which will be checked after 6 months. The study status is currently unclear, and about 50 people are expected to participate.

Study design
This is a randomized study, meaning you would be placed into one of two groups by chance: either the ACT Lung Health Intervention or standard care. About 50 participants are expected to join.
What's involved
You would undergo screening to see if you qualify, complete questionnaires, and provide saliva samples. Your participation is expected to last about 6 months.
Compensation
Not stated in the trial record.
Follow-up
The main goal of the study is measured 6 months after your initial assessment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06945120

ACT Lung Health Intervention: Phase Two

Recruiting
NAAges 18+InterventionalHealth services
Dana-Farber Cancer Institute
~50 participants
Updated 2026-03-13 on ClinicalTrials.gov
What's tested:ACT Lung Health Intervention

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Biochemically Verified 7-Day Point Prevalence Smoking Abstinence at 6 Months (Group A)
Measured over 6 months post-baseline assessment
+1 more outcome measured

Conditions

Smoking Cessation
Smoking Behaviors
Smoking, Tobacco
Smoking, Cigarette
Smoking (Tobacco) Addiction

Explore related trials

Lung CarcinomaSmoking Cessation

Where it's being run

2 sites across 1 states
Massachusetts2

Study leadership

  • Mary Cooley, PhD · PRINCIPAL_INVESTIGATOR · Dana-Farber Cancer Institute

Who to contact

Mary Cooley, PhD
[email protected]
617-632-5096
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Self-identify as either Chinese or Korean
Speak either Korean, Mandarin, or English
Are 18 years of age or older
Are current smokers (i.e., have smoked at least 100 traditional cigarettes ever and have smoked at least one traditional cigarette within the prior 30 days)
Will live in the United States for the next 12 months

Exclusion

Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months.
We will not include any of the following special populations:
Adults unable to consent.
Adults younger than 50 or older than 80 years
Individuals who are not yet adults (infants, children, teenagers)
Pregnant women
Prisoners

What this trial measures

  • Biochemically Verified 7-Day Point Prevalence Smoking Abstinence at 6 Months (Group A)6 months post-baseline assessment

    The proportion of participants who have not smoked cigarettes (not even a puff) in the past 7 days at the 6-month follow-up, verified biochemically using salivary cotinine testing. Participants reporting abstinence and not using nicotine replacement therapy (NRT) will perform a salivary cotinine test observed via video call. Cotinine levels ≤3 ng/mL will confirm abstinence.

  • Biochemically Verified 7-Day Point Prevalence Smoking Abstinence at 6 Months (Group B)6 months post-baseline assessment

    The proportion of participants who have not smoked cigarettes (not even a puff) in the past 7 days at the 6-month follow-up, verified biochemically using salivary cotinine testing. Participants reporting abstinence and not using nicotine replacement therapy (NRT) will perform a salivary cotinine test observed via video call. Cotinine levels ≤3 ng/mL will confirm abstinence.